Izumi Kamo

1.1k citations
34 papers · 859 indexed · h-index 18

Izumi Kamo

34 papers receiving 812 citations

Peers

Izumi Kamo
Comparison fields: 5 of 74
  • Urology 516
  • Rheumatology 414
  • Cellular and Molecular Neuroscience 135
  • Endocrine and Autonomic Systems 38
  • Organic Chemistry 137
Replace Valerie C. Lowe with:
Valerie C. Lowe United States
Pietro Barbacini Italy
Xiaopu Liu United States
Zhongqing Wei China
Thomas A. Fey United States
C. Sultan France
Taylor Peak United States
Marilyn Grous United States
Mei‐Chyn Chao Taiwan
Yasuhiro Naiki Japan
Izumi Kamo relative to Valerie C. Lowe United States Valerie C. Lowe's profile →
Citations per field
00.5×10×20×25.9×
Valerie C. Lowe · 1×
Citations per year

Countries citing papers authored by Izumi Kamo

Since Specialization
Citations

This map shows the geographic impact of Izumi Kamo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izumi Kamo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izumi Kamo more than expected).

Fields of papers citing papers by Izumi Kamo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Izumi Kamo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izumi Kamo. The network helps show where Izumi Kamo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Izumi Kamo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Izumi Kamo Line = papers co-authored together Izumi Kamo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20213
2 20168
3 20156
4 20111
5 20112
6 200846
7 200719
8 200562
9 200538
10 200474
11 200389
12 20018
13 200019
14 200022
15 199917
16 199715
17 199564
18 19899
19 19884
20 198825

About Izumi Kamo

Izumi Kamo is a scholar working on Urology, Rheumatology and Cellular and Molecular Neuroscience, having authored 34 papers that have together received 859 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (21 papers), Pelvic floor disorders treatments (13 papers), Neuropeptides and Animal Physiology (10 papers), Urinary Tract Infections Management (6 papers), Urological Disorders and Treatments (6 papers), Receptor Mechanisms and Signaling (6 papers), Pain Mechanisms and Treatments (3 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). The work is most often cited by research in Urology (516 citations), Rheumatology (414 citations) and Cellular and Molecular Neuroscience (135 citations). Izumi Kamo has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Naoki Yoshimura, Michael B. Chancellor, William C. de Groat, Kazumasa Torimoto, Takayuki Doi, Tracy W. Cannon, Yoshinori Ikeura, Hideaki Natsugari, Yasuhiro Kaiho and D. Conway. Their work appears in journals such as American Journal of Physiology-Renal Physiology, Bioorganic & Medicinal Chemistry, European Journal of Pharmacology, The Journal of Urology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026